SLS Other Income/Expenses (Net)
Sellas Life Sciences Group Inc · Other Income/Expenses (Net)
SLS Other Income/Expenses (Net)
Latest reported$2.76Mperiod ending
SLS TTM Other Income/Expenses (Net) ($245.00K → $2.76M)
TTM Other Income/Expenses (Net)
High-resolution chart · PNG
SLS other income/expenses (net) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Other Income/Expenses (Net) (USD) |
|---|---|
| 2,758,000 | |
| 2,006,000 | |
| 1,411,000 | |
| 995,000 | |
| 924,000 | |
| 803,000 | |
| 632,000 | |
| 492,000 | |
| 365,000 | |
| 424,000 | |
| 529,000 | |
| 813,000 | |
| 843,000 | |
| 842,000 | |
| -9,351,000 | |
| -10,592,000 | |
| -10,824,000 | |
| -11,193,000 | |
| -1,342,000 | |
| 0 | |
| 127,000 | |
| 129,000 | |
| 208,000 | |
| 12,323,000 | |
| 12,286,000 | |
| 13,329,000 | |
| 13,230,000 | |
| -7,882,000 | |
| -5,093,000 | |
| -5,376,000 | |
| -7,509,000 | |
| 1,716,000 | |
| -2,786,000 | |
| -3,516,000 | |
| 1,601,000 | |
| 6,390,000 | |
| 10,251,000 | |
| 27,949,000 | |
| 21,752,000 | |
| 13,457,000 | |
| 13,610,000 | |
| -8,793,000 | |
| -4,796,000 | |
| 1,482,000 | |
| 6,164,000 | |
| 6,839,000 | |
| 15,546,000 | |
| -22,917,000 | |
| -31,117,000 | |
| -27,029,000 | |
| -41,786,000 | |
| -1,171,000 | |
| -669,000 | |
| 5,311,000 | |
| -8,375,000 | |
| -6,554,000 | |
| -7,861,000 | |
| -13,089,000 | |
| 7,475,000 | |
| -6,080,000 | |
| -4,456,000 | |
| -2,525,000 | |
| -3,389,000 | |
| -5,251,000 | |
| -2,843,000 | |
| -5,462,000 | |
| -6,032,000 | |
| 2,015,000 | |
| 79,000 | |
| 113,000 | |
| 105,000 | |
| 220,000 | |
| 265,000 | |
| 237,000 | |
| 245,000 | |
| 101,000 |